Advancing IgAN Care: Exploring the Next Wave of Treatments - Episode 18
The Promise of Emerging IgAN Therapies
Panelists discuss how emerging therapies are expected to address the unmet need for treatments that not only reduce proteinuria but also target the underlying immune dysfunction associated with IgA nephropathy.
- How do you believe emerging therapies will address the unmet need for treatments that reduce proteinuria while also modifying the disease’s underlying immune dysfunction?
- What are the most promising mechanisms of action being explored in these new therapies?
